Cargando…

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor

Detalles Bibliográficos
Autores principales:	Zech, Fabian, Weber, Stefanie, Dietenberger, Hanna, Zhang, Linyun, Noettger, Sabrina, Volcic, Meta, Bergner, Tim, Read, Clarissa, Sparrer, Konstantin M. J., Barth, Thomas F. E., Kirchhoff, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200011/ https://www.ncbi.nlm.nih.gov/pubmed/37211548 http://dx.doi.org/10.1038/s41392-023-01492-7

Ejemplares similares

Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2
por: Xie, Qinya, et al.
Publicado: (2023)

Determinants of species-specific utilization of ACE2 by human and animal coronaviruses
por: Wang, Qingxing, et al.
Publicado: (2023)

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization
por: Pastorio, Chiara, et al.
Publicado: (2023)

Near-Native Visualization of SARS-CoV-2 Induced Membrane Remodeling and Virion Morphogenesis
por: Bergner, Tim, et al.
Publicado: (2022)

Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
por: Pastorio, Chiara, et al.
Publicado: (2022)

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
por: Nchioua, Rayhane, et al.
Publicado: (2022)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
por: Nchioua, Rayhane, et al.
Publicado: (2023)

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
por: Jung, Christoph, et al.
Publicado: (2022)

SARS-CoV-2 Nsp1: Ein kleines Protein blockiert die Immunantwort
por: Sparrer, Konstantin, et al.
Publicado: (2021)

IFI16 knockdown in primary HIV-1 target cells
por: Bosso, Matteo, et al.
Publicado: (2020)

Surface functionalization affects the retention and bio-distribution of orally administered mesoporous silica nanoparticles in a colitis mouse model
por: Schmid, Roman, et al.
Publicado: (2023)

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
por: Nchioua, Rayhane, et al.
Publicado: (2022)

Manipulation of autophagy by SARS-CoV-2 proteins
por: Koepke, Lennart, et al.
Publicado: (2021)

Interferon antagonists encoded by SARS-CoV-2 at a glance
por: Lee, Jung-Hyun, et al.
Publicado: (2022)

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
por: Case, James Brett, et al.
Publicado: (2020)

HIV protease: late action to prevent immune detection
por: Sparrer, Konstantin M. J., et al.
Publicado: (2021)

Cap snatch prevention: a novel approach to tackle influenza viruses
por: Sparrer, Konstantin M. J., et al.
Publicado: (2023)

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
por: Xiong, Hua-Long, et al.
Publicado: (2020)

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
por: Prelli Bozzo, Caterina, et al.
Publicado: (2021)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells
por: Bosso, Matteo, et al.
Publicado: (2020)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2023)

Growth hormone–releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice
por: Condor Capcha, Jose M., et al.
Publicado: (2023)

CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin
por: Hirschenberger, Maximilian, et al.
Publicado: (2021)

Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins
por: Hirschenberger, Maximilian, et al.
Publicado: (2021)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Emergence of SARS‐CoV‐2 spike protein at the vaccination site
por: Beck, Annika, et al.
Publicado: (2023)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Development and Applications of VSV Vectors Based on Cell Tropism
por: Tani, Hideki, et al.
Publicado: (2012)

Titration methods for rVSV-based vaccine manufacturing
por: Gélinas, Jean-François, et al.
Publicado: (2020)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis
por: Fensterl, Volker, et al.
Publicado: (2012)

Variants of Escherichia coli Subtilase Cytotoxin Subunits Show Differences in Complex Formation In Vitro
por: Krause, Maike, et al.
Publicado: (2019)

Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion
por: Libersou, Sonia, et al.
Publicado: (2010)

Characterization of Monomeric Intermediates during VSV Glycoprotein Structural Transition
por: Albertini, Aurélie A., et al.
Publicado: (2012)

Evaluation of a replication-competent VSV-SIV vaccine candidate
por: Jurgens, CK, et al.
Publicado: (2012)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ei3nch13dfr03t0l6r8lrj7t6c